Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Mayank Goyal, Andrew M. Demchuk, Bijoy K. Menon, Muneer Eesa, Jeremy Rempel, John Thornton, Daniel Roy, Tudor G. Jovin, Robert A. Willinsky, Biggya L. Sapkota, Dar D Dowlatshahi, Donald F. Frei, Noreen R. Kamal, Walter J. Montanera, Alexandre Yves Poppe, Karla J. Ryckborst, Frank L. Silver, Ashfaq M Shuaib, Donatella I Tampieri, David James Williams, Oh Young Bang, Blaise Baxter, Paul Burns, Hana Choe, Ji Hoe Heo, Christine Anne Holmstedt, Brian Thomas Jankowitz, Michael Kelly, Guillermo Linares, Jennifer L. Mandzia, Jai Shankar, Sung‐Il Sohn, Richard H. Swartz, Philip A. Barber, Shelagh B. Coutts, Eric Edward Smith, William F. Morrish, Alain Weill, Suresh Subramaniam, Alim P. Mitha, John H. Wong, Mark W. Lowerison, Tolulope T. Sajobi, Michael D. Hill
New England Journal of Medicine · 2015 · 6,212 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Goyal, M., Demchuk, A. M., Menon, B. K., Eesa, M., Rempel, J., Thornton, J., Roy, D., Jovin, T. G., Willinsky, R. A., Sapkota, B. L., Dowlatshahi, D. D., Frei, D. F., Kamal, N. R., Montanera, W. J., Poppe, A. Y., Ryckborst, K. J., Silver, F. L., Shuaib, A. M., Tampieri, D. I., … Hill, M. D. (2015). Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine, 372(11), 1019–1030. https://doi.org/10.1056/nejmoa1414905
In text: (Goyal et al., 2015)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
BACKGROUND: Among patients with a proximal vessel occlusion in the anterior circulation, 60 to 80% of patients die within 90 days after stroke onset or do not regain functional independence despite alteplase treatment. We evaluated rapid endovascular treatment in addition to standard care in patients with acute ischemic stroke with a small infarct core, a proximal intracranial arterial occlusion, and moderate-to-good collateral circulation. METHODS: We randomly assigned participants to receive standard care (control group) or standard care plus endovascular treatment with the use of available thrombectomy devices (intervention group). Patients with a proximal intracranial occlusion in the anterior circulation were included up to 12 hours after symptom onset. Patients with a large infarct core or poor collateral circulation on computed tomography (CT) and CT angiography were excluded. Workflow times were measured against predetermined targets. The primary outcome was the score on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) at 90 days. A proportional odds model was used to calculate the common odds ratio as a measure of the likelihood that the intervention would lead to lower scores on the modified Rankin scale than would control care (shift analysis). RESULTS: The trial was stopped early because of efficacy. At 22 centers worldwide, 316 participants were enrolled, of whom 238 received intravenous alteplase (120 in the intervention group and 118 in the control group). In the intervention group, the median time from study CT of the head to first reperfusion was 84 minutes. The rate of functional independence (90-day modified Rankin score of 0 to 2) was increased with the intervention (53.0%, vs. 29.3% in the control group; P<0.001). The primary outcome favored the intervention (common odds ratio, 2.6; 95% confidence interval, 1.7 to 3.8; P<0.001), and the intervention was associated with reduced mortality (10.4%, vs. 19.0% in the control group; P=0.04). Symptomatic intracerebral hemorrhage occurred in 3.6% of participants in intervention group and 2.7% of participants in control group (P=0.75). CONCLUSIONS: Among patients with acute ischemic stroke with a proximal vessel occlusion, a small infarct core, and moderate-to-good collateral circulation, rapid endovascular treatment improved functional outcomes and reduced mortality. (Funded by Covidien and others; ESCAPE ClinicalTrials.gov number, NCT01778335.).
Related papers
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.1993
- Tissue Plasminogen Activator for Acute Ischemic Stroke1995
- Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis2014
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation2009
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2020
Metadata from OpenAlex (CC0). Citations are generated from the published record.